Abstract-The usefulness of control theory to model robustness in metabolic pathways is limited because controller properties and their implications on pathway regulation are unclear. Using sphingolipid biosynthesis in response to single-gene overexpression as a case study, we apply model-reference adaptive control (MRAC) to model regulation in a mass action kinetics pathway model and report on its properties. Tracking error between treated cells (plant) and wild type (reference) is reduced in 9 of 10 system variables compared to using mass action kinetics only. This result is robust when system parameters are perturbed. Furthermore, we interpret control dynamics to infer potential regulatory interactions. Some observations are consistent with independent studies on the effects of the same experimental treatment, while others represent novel hypotheses that may be tested to yield additional biological insight. The usefulness and interpretation of MRAC to model metabolic pathway regulation is shown where plant dynamics approach the reference.
INTRODUCTION
Robust behavior in metabolic pathways suggests that biological systems may be reverse engineered using control theory [1] , e.g., in bacterial chemotaxis [2] , heat shock response [3] , and amino acid regulation [4] . However, the usefulness of control theory to model robustness in metabolic pathways is still limited because properties of specific controllers and their implications to model pathway regulation are not well understood. Here, we use feedback control, namely model-reference adaptive control (MRAC), as a model of metabolic pathway regulation, and report on its efficacy and robustness in terms of tracking error. As a case study, we use sphingolipid de novo synthesis in human embryonic kidney (HEK) cells in response to single-gene overexpression, specifically SPT that codes for serine palmitoyl-transferase.
This report extends previous work that demonstrated the original use of MRAC to infer potential regulatory interactions [5] . Specifically, we (a) assess the efficacy and robustness of the proposed controller using MRAC in terms of tracking error, i.e., how closely the plant dynamics follow the reference dynamics, and (b) interpret the control and feedback dynamics in the context of relevant literature for potential insight into sphingolipid de novo synthesis pathway regulation.
A. Sphingolipid de novo synthesis
Sphingolipids are involved in key eukaryotic cell functions such as membrane structure, signaling, and metabolism. Regulation of sphingolipid levels through synthesis is important because its pathway intermediates are highly bioactive (Fig. 1) . Alterations in sphingolipid synthesis, storage, and metabolism are implicated in human diseases [6] . 
B. Model-reference adaptive control (MRAC)
The goal of model-reference adaptive control (Fig. 2) is to regulate an unknown system of interest (plant) using adaptive feedback such that it behaves identically to a known model (reference) [7] . In this case, because sphingolipid amounts in treated cells are observed to approach the wild type over time under similar experimental conditions, i.e., SPT overexpression, the wild type pathway is defined as the reference while the treated cells pathway is defined as the plant.
II. MATERIALS AND METHODS

A. Sphingolipid data acquisition
Sphingolipids, i.e., sphingoid bases and (dihydro)N-acyl species, are extracted from samples of cultured human embryonic kidney (HEK) cells and quantified by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) as described previously [8] .
Measurements from four technical replicates are taken at hour intervals from 0-6 hours inclusive.
B. Reaction kinetics
The equations of motion, i.e., biochemical reactions, can be written as a (linear) system of ordinary differential equations (ODEs) using mass action kinetics, e.g.,
where k a,b indicates the rate constant for the reaction from a to b (see [5] for details of other pathway reactions). Rate constants are estimated using data from the C16 dual-chain labeled species. The genetic algorithm was implemented for to estimate these system parameters based on minimizing least-squares error [9] .
C. Model-reference adaptive control (MRAC)
The state space is defined as a 10x1 vector:
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The state dynamics for the reference (wild type) and plant (treated cells) are:
where ‫ݔ‬ റ ሺ‫ݐ‬ሻ represents sphingolipid amounts in the reference and ‫ݔ‬ റሺ‫ݐ‬ሻ in the plant. The system parameters (reaction rate constants k a,b ) are contained in the matrices A m and A. The scalar input r(t) represents the system input palmitoyl-coA (PalCoA). ܾ ሬറ and ܾ ሬറ are actuation vectors. The scalar controller u(t) is the sum of two components, input PalCoA and state feedback:
where h x (t), h r (t) are adaptation gains associated with state feedback and system input respectively. Using the Lyapunov synthesis method, the rate of change of these adaptation gains are defined:
Potential regulatory pathway interactions may be inferred from these adaptation gain dynamics, where ݁ റሺ‫ݐ‬ሻ is the difference between plant and reference states:
and ǡ ࢽ are control parameters to be specified. P satisfies the Lyapunov equation: ൌ
and can be solved by specifying Q. Finally, the initial conditions may be chosen by matching:
to approximate the ideal constant gains. The model is implemented in MATLAB.
Tracking error between the plant (treated cells) and reference (wild type) dynamics is quantified using the L2-norm, or root-sum-square error (RSS).
In addition, robustness is also tested when system parameters are perturbed by varying the reaction rate constants individually, i.e., k perturbed = k original * {10 -1 , 10 1 }.
III. RESULTS AND DISCUSSION
A. Pathway dynamics Experimental data and simulated pathway dynamics are shown in Fig.s 3 (wild Fig. 6 shows tracking error between t wild type. Tracking error is smaller in 9 of except SM, using MRAC compared to m When rate constants are varied, the mean also smaller in 9 of 10 sphingolipid (statist reaction kinetics ay dynamics. d dynamics are not for DHCer, ited for DHCer, for Sa and SaP. Fig. 4 ), simulated GC, GC, and SM, DHCer, DHSM, g. 5), simulated , and DHSM, but range) and simulated phingolipid amounts urs) range) and simulated ack; y-axiss-time (hours) treated cells and 10 sphingolipids, mass action only.
B. Tracking error
tracking error is tically significant for Sa, SaP, and DHGC), exce compared to mass action only. Fig. 7 shows that the amount of the pathway is first quickly mode gradually inhibited over time. Path factor at first, but is later enhanc pathway regulation may occur at th by moderating the reaction substrat control design, such a regulatory st and requires the least relative effo ept SM, using MRAC cells and wild type: MA-mass adaptive feedback (hollow bars, viation; difference in means is d t-test) for Sa, SaP, and DG n treated cells in terms of put PalCoA, u r (t), and (b) Fig. 8 shows feedback metabolites, in terms of In both figures, the ss, where magnitude and y regulation, i.e., larger ctivity, sign indicates ells, in terms of system input hway metabolites, ux(t) (red) -(dimensionless), error bars: ion input PalCoA that enters erated at the onset, then hway feedback is a lesser ced. This suggests that he source of perturbation te (PalCoA). In terms of trategy is highly efficient fort to implement. This strategy may also explain how pathway fe significant factor at the onset.
The possibility that PalCoA may be m case may also be a result of using only sphingolipids such that labeled PalCoA on moderated relative to the total intracellular be tested by tracking unlabeled PalCoA a other hand, if the amount of available Pa moderated biologically in response to t studies may focus on elucidating molecular could accomplish this. For instance, poss could slow the rate of uptake of extracellula reduce the rate of converting palmitate increase the rate of other metabolic react PalCoA as a substrate. In Fig. 8 , relative to other metabolites, fe SoP, DHCer, DHGC, and DHSM change also exhibit similar trends, i.e., to incre quickly from zero initial condition and then over time. This suggests that these metab active roles in pathway regulation. metabolites are also signaling molecule opposing responses. For example, Sa a growth inhibition [11] and activates gro [12] , while So and Cer activate growth Hence, taken together, these feedback dynam SPT overexpression at these levels le stimulation in HEK cells, which is independent studies on the same experim [14] .
IV. CONCLUSION
Using a case study pathway, we first property of MRAC is to reduce the trackin the plant (treated cells) and reference (w feature is robust when system parameter Then, we interpreted control and feedback d interactions that may be responsible for re feedback is not a moderated in this data on labeled nly appears to be pool. This may as well. On the alCoA is indeed treatment, future mechanisms that ible mechanisms ar palmitate [10] 
